Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
Glycogen Storage Disease Type IA
Interventions
BIOLOGICAL

[6,6-2H2]glucose

Each subject will be administered two oral \[6,6-2H2\]glucose loads (pre-prandial, fed) in the hospital setting and one oral \[6,6-2H2\]glucose load at home setting (random time). Capillary blood samples will be collected on filter paper 10 times at specific time points after each oral \[6,6-2H2\]glucose load.

Trial Locations (1)

Unknown

University of Groningen, UMC Groningen, Groningen

All Listed Sponsors
collaborator

Ultragenyx Pharmaceutical Inc

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT04311307 - Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia | Biotech Hunter | Biotech Hunter